Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(5), P. 673 - 673
Published: May 20, 2025
Hepatocellular
carcinoma
(HCC)
is
an
aggressive
and
prevalent
liver
cancer
with
a
poor
prognosis.
Nanotechnology
combined
natural
products
has
emerged
as
promising
strategy
to
enhance
HCC
treatment
efficacy.
This
review
assesses
the
current
literature
on
application
of
nanotechnology
in
delivering
for
therapy.
A
comprehensive
search
was
conducted
PubMed,
Science
Direct,
Web
Science,
Google
Scholar
identify
relevant
studies
published
up
present
articles
focusing
nanotechnology-based
drug
delivery
systems
using
therapy,
including
different
nanoparticle
(NP)
formulations
therapeutic
interventions,
were
included.
Natural
anticancer
properties
have
been
encapsulated
various
nanocarriers
such
liposomes,
polymeric
nanoparticles,
quantum
dots,
which
improved
stability,
prolonged
circulation
time,
enhanced
targeted
cells.
These
advancements
led
increased
efficacy
reduced
side
effects.
Additionally,
combining
multiple
or
integrating
them
conventional
therapies
via
enables
personalized
approaches
based
patient
characteristics
molecular
profiles.
The
integration
shows
great
potential
improving
outcomes,
representing
significant
advancement
precision
medicine
paving
way
more
effective
strategies.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(8)
Published: Jan. 18, 2023
Abstract
Fast
and
selective
fluorescence
imaging
for
a
biomarker
to
related‐disease
diagnosis
remains
significant
challenge
due
complex
physical
environment.
Human
carboxylesterase
(CE)
is
expected
be
potential
of
hepatocellular
carcinoma
(HCC)
improve
the
accuracy
diagnosis.
However,
existing
probes
CE
has
slow
response
rate
low
selectivity.
Herein,
amide
group
selected
as
CE‐responsive
sites
based
on
“substrate‐hydrolysis
enzymatic
reaction”
approach.
From
series
off–on
with
leave
groups
in
unit,
probe
J
screened
optimal
combination
rapid
high
selectivity
toward
CE.
requires
only
150
s
reach
maximum
at
676
nm
presence
free
from
interference
other
esterase.
Computational
docking
simulations
indicate
shortest
distance
between
active
site
.
Cell
vivo
present
that
can
turn
liver
cancer
cells
tumor
region
precisely.
Importantly,
allowed
specifically
image
orthotopic
rather
than
metastatic
distinguish
human
primary
tissue
adjacent
ones.
This
study
provides
new
tool
detection
promotes
advancements
accurate
HCC
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(32)
Published: May 23, 2024
Clear
delineation
of
tumor
margins
is
essential
for
accurate
resection
and
decreased
recurrence
rate
in
the
clinic.
Fluorescence
imaging
emerging
as
a
promising
alternative
to
traditional
visual
inspection
by
surgeons
intraoperative
imaging.
However,
probes
lack
accuracy
diagnosis,
making
it
difficult
depict
boundaries
accurately.
Herein,
we
proposed
an
offensive
defensive
integration
(ODI)
strategy
based
on
"attack
systems
(invasive
peptidase)
defense
(reductive
microenvironment)"
multi-dimensional
characteristics
design
activatable
fluorescent
precisely.
Screened
out
from
series
ODI
strategy-based
probes,
ANQ
performed
better
than
unilateral
correlation
distinguishing
between
cells
normal
minimizing
false-positive
signals
living
metabolic
organs.
To
further
improve
signal-to-background
ratio
vivo,
derivatized
FANQ,
was
prepared
successfully
applied
distinguish
orthotopic
hepatocellular
carcinoma
tissues
adjacent
mice
models
clinical
samples.
This
work
highlights
innovative
develop
rapid
diagnosis
tumors
high-precision
boundaries,
providing
more
efficient
tools
future
applications
assisted
resection.
Journal of the American Chemical Society,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 4, 2025
Liver
disease
poses
a
significant
challenge
to
global
health,
and
its
early
diagnosis
is
crucial
for
improving
treatment
outcomes
patient
prognosis.
Since
fluctuation
of
key
biomarkers
during
the
onset
progression
liver
diseases
can
directly
reflect
health
normal/abnormal
function,
biomarker-based
assays
are
vital
tools
detection
disease.
In
this
context,
small
molecule
fluorescent
probes
have
undeniably
emerged
as
indispensable
analysis,
with
an
ever-growing
number
molecule-based
being
developed
over
recent
years,
sole
aim
monitoring
relevant
This
perspective
will
focus
on
development
application
primarily
last
10
years
diagnosing
range
disease-related
processes.
It
outline
foundational
design
strategies
developing
promising
probes,
their
optical
response
biomarkers,
how
they
been
demonstrated
in
proof-of-concept
imaging
applications.
Current
challenges
new
developments
field
be
discussed,
providing
insights
highlighting
opportunities
field.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(18)
Published: April 28, 2023
Near-infrared
fluorescence
imaging
is
vital
for
exploring
the
biological
world.
The
short
emissions
(<650
nm)
and
small
Stokes
shifts
(<30
of
current
xanthene
dyes
obstruct
their
applications
since
a
long
time.
Recently,
potent
universal
THQ
structural
modification
technique
that
emission
to
NIR-I/II
range
enables
substantial
shift
(>100
THQ-modified
established.
Thus,
timely
discussion
THQ-xanthene
its
extensive.
Hence,
advent,
working
principles,
development
trajectory,
dyes,
especially
in
fields
probe-based
sensing
imaging,
cancer
theranostics,
super-resolution
are
introduced.
It
envisioned
tactic
simple
yet
exceptional
approach
upgrade
performance
conventional
dyes.
will
advance
strides
xanthene-based
potentials
early
fluorescent
diagnosis
diseases,
imaging-guided
surgery.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(7)
Published: Jan. 19, 2024
Hepatocellular
carcinoma
(HCC)
has
gradually
become
a
pronoun
for
terrifying
death
owing
to
its
high
mortality
rate.
With
the
progression
of
HCC,
lipid
droplets
(LDs)
in
HCC
cells
exhibit
specific
variations
such
as
increased
LDs
number
and
decreased
polarity,
which
can
serve
diagnostic
target.
However,
developing
an
effective
method
achieve
diagnosis
reveal
polarity
heterogeneity
is
still
crucial
challenge.
Herein,
first
high-performance
LDs-targeting
probe
(1)
reported
based
on
ketocyanine
strategy
with
ultrasensitive
polarity-responding
ability
near-infrared
emission.
Probe
1
shows
excellent
sensitivity
parameter
Δf
(0.027-0.290)
808-fold
fluorescence
enhancement
emission
wavelength
red-shifts
91
nm.
In
cells,
2.5-
5.9-fold
compared
normal
other
cancer
exceeds
clinical
threshold
2.0,
indicating
distinguish
cells.
The
revealed
it
displays
sequence,
<
may
provide
useful
insight
engineer
probes
cell
discrimination.
Finally,
realizes
accurate
cellular,
organ,
vivo
levels,
providing
satisfying
tool
surgical
navigation.
Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
96(6), P. 2369 - 2377
Published: Feb. 4, 2024
Ultrasensitive
and
accurate
monitoring
of
carboxylesterase
(CE)
activity
is
extremely
crucial
for
the
early
diagnosis
hepatocellular
carcinoma
(HCC),
which
still
a
considerable
challenge.
Herein,
using
co-reactive
ligand
engineering
strategy,
ultra-bright
near-infrared
(λmax
=
830
nm)
self-enhanced
electrochemiluminescence
(ECL)
Au
nanoclusters
(NCs)
were
in
situ
prepared
with
2-(diethylamino)
ethanethiol
(DEAET)
as
ligand.
Remarkably,
not
only
acts
stabilizer
like
traditional
ligands
but
also
plays
role
co-reactant
to
ensure
confinement
effect
shorten
charge
transfer
distance
increase
local
concentration,
significantly
improving
collision
efficiency
between
electrogenerated
free
radicals.
Consequently,
DEAET
NCs
exhibited
record
stable
anodal
ECL
without
addition
an
exogenous
co-reactant,
dramatically
superior
classical
Ru(bpy)32+
certain
amount
co-reactant.
As
proof
concept,
convenient
label-free
CE
biosensor
was
innovatively
constructed
1-naphthyl
acetate
selective
substrate,
achieving
ultrasensitive
detection
low
limit
9.1
×
10–7
U/L.
Therefore,
this
work
paves
strategy
preparation
high-efficiency
metal
provides
platform
HCC.